Orchestra BioMed
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $30,917 | $861 | $836 | $868 |
Gross Profit | 30,866 | 812 | 790 | 824 |
EBITDA | 6,836 | -20,232 | -19,246 | -18,672 |
EBIT | 6,754 | -20,313 | -19,327 | -18,755 |
Net Income | 6,245 | -20,828 | -19,363 | -18,755 |
Net Change In Cash | 30,917 | 861 | 836 | 868 |
Free Cash Flow | -2,303 | -14,860 | -15,561 | -16,728 |
Cash | 34,690 | 42,012 | 18,749 | 18,348 |
Basic Shares | 38,392 | 38,392 | 38,392 | 38,235 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $33,482 | $2,638 | $2,760 | $3,533 |
Gross Profit | 33,292 | 2,434 | 2,574 | 3,211 |
EBITDA | -51,480 | -63,993 | -51,219 | -32,435 |
EBIT | -51,807 | -64,301 | -51,506 | -32,657 |
Net Income | -52,955 | -61,024 | -49,120 | -33,608 |
Net Change In Cash | 33,482 | 2,638 | 2,760 | 3,533 |
Free Cash Flow | -49,452 | -50,847 | -46,205 | -29,880 |
Cash | 34,690 | 22,261 | 30,559 | 19,784 |
Basic Shares | 38,392,716 | 36,821 | 33,225 | 25,472 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.26 |
2025-09-30 | -$0.40 |
2025-06-30 | -$0.50 |
2025-03-31 | -$0.49 |
